Back to Search Start Over

Supplementary Figure 3 from Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer

Authors :
Xingming Deng
Fadlo R. Khuri
Walter J. Curran
Suresh S. Ramalingam
Gabriel L. Sica
Taofeek K. Owonikoko
Zhuo G. Chen
Shi-Yong Sun
Zhongliang Hu
Rui Li
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

PDF file, 78K, Treatment of mice with human lung cancer HCC827/ER xenografts using a combination of erlotinib and niclosamide results in a long term tumor-free survival.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....1edf04b65457e9318692a21d1116d6c5